Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin and VR Exposure Therapy in PTSD
NCT02308202Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of doxazosin in post-traumatic stress disorder (PTSD), sponsored by Baylor College of Medicine. Primary endpoint: Subjective Units of Distress Scale at 16 days. Started Jan 2012; status: completed.
02
Drugs
doxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02308202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308202.